294 related articles for article (PubMed ID: 27798034)
21. Prophylactic platelet transfusions in hospitalised patients with thrombocytopenia-Protocol for a systematic review with meta-analysis.
Anthon CT; Sivapalan P; Granholm A; Pène F; Puxty K; Perner A; Møller MH; Russell L
Acta Anaesthesiol Scand; 2021 Aug; 65(7):988-994. PubMed ID: 33840095
[TBL] [Abstract][Full Text] [Related]
22. A no-prophylaxis platelet-transfusion strategy for hematologic cancers.
Stanworth SJ; Estcourt LJ; Powter G; Kahan BC; Dyer C; Choo L; Bakrania L; Llewelyn C; Littlewood T; Soutar R; Norfolk D; Copplestone A; Smith N; Kerr P; Jones G; Raj K; Westerman DA; Szer J; Jackson N; Bardy PG; Plews D; Lyons S; Bielby L; Wood EM; Murphy MF;
N Engl J Med; 2013 May; 368(19):1771-80. PubMed ID: 23656642
[TBL] [Abstract][Full Text] [Related]
23. Neonatal Platelet Transfusions and Future Areas of Research.
Sola-Visner M; Bercovitz RS
Transfus Med Rev; 2016 Oct; 30(4):183-8. PubMed ID: 27282660
[TBL] [Abstract][Full Text] [Related]
24. Platelet Transfusions in Patients with Hypoproliferative Thrombocytopenia: Conclusions from Clinical Trials and Current Controversies.
Crighton GL; Estcourt LJ; Wood EM; Stanworth SJ
Hematol Oncol Clin North Am; 2016 Jun; 30(3):541-60. PubMed ID: 27112995
[TBL] [Abstract][Full Text] [Related]
25. A randomized study of buffy coat platelets in platelet additive solution stored 1-5 versus 6-7 days prior to prophylactic transfusion of allogeneic haematopoietic progenitor cell transplant recipients.
Diedrich B; Ringdén O; Watz E; Shanwell A
Vox Sang; 2009 Oct; 97(3):254-9. PubMed ID: 19508669
[TBL] [Abstract][Full Text] [Related]
26. Prophylactic tranexamic acid in patients with hematologic malignancy: a placebo-controlled, randomized clinical trial.
Gernsheimer TB; Brown SP; Triulzi DJ; Key NS; El Kassar N; Herren H; Poston JN; Boyiadzis M; Reeves BN; Selukar S; Pagano MB; Emerson S; May S
Blood; 2022 Sep; 140(11):1254-1262. PubMed ID: 35667085
[TBL] [Abstract][Full Text] [Related]
27. A study protocol for a randomised controlled trial evaluating clinical effects of platelet transfusion products: the Pathogen Reduction Evaluation and Predictive Analytical Rating Score (PREPAReS) trial.
Ypma PF; van der Meer PF; Heddle NM; van Hilten JA; Stijnen T; Middelburg RA; Hervig T; van der Bom JG; Brand A; Kerkhoffs JL;
BMJ Open; 2016 Jan; 6(1):e010156. PubMed ID: 26817642
[TBL] [Abstract][Full Text] [Related]
28. A controlled trial of tranexamic acid therapy for the reduction of bleeding during treatment of acute myeloid leukemia.
Shpilberg O; Blumenthal R; Sofer O; Katz Y; Chetrit A; Ramot B; Eldor A; Ben-Bassat I
Leuk Lymphoma; 1995 Sep; 19(1-2):141-4. PubMed ID: 8574160
[TBL] [Abstract][Full Text] [Related]
29. Platelet transfusions in adult thrombocytopenic ICU patients: Protocol for a sub-study of the PLOT-ICU cohort.
Anthon CT; Pène F; Perner A; Azoulay E; Puxty K; Van De Louw A; Chawla S; Castro P; Povoa P; Coelho L; Metaxa V; Kochanek M; Liebregts T; Kander T; Sivula M; Møller MH; Russell L
Acta Anaesthesiol Scand; 2024 Mar; 68(3):434-440. PubMed ID: 38115558
[TBL] [Abstract][Full Text] [Related]
30. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions.
Casati V; Guzzon D; Oppizzi M; Bellotti F; Franco A; Gerli C; Cossolini M; Torri G; Calori G; Benussi S; Alfieri O
J Thorac Cardiovasc Surg; 2000 Sep; 120(3):520-7. PubMed ID: 10962414
[TBL] [Abstract][Full Text] [Related]
31. Platelet transfusions and predictors of bleeding in patients with myelodysplastic syndromes.
Mo A; Wood E; Shortt J; Hu E; McQuilten Z
Eur J Haematol; 2023 Oct; 111(4):592-600. PubMed ID: 37452616
[TBL] [Abstract][Full Text] [Related]
32. How well do platelets prevent bleeding?
Triulzi DJ
Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):518-522. PubMed ID: 33275687
[TBL] [Abstract][Full Text] [Related]
33. Prediction of bleeding and prophylactic platelet transfusions in cancer patients with thrombocytopenia.
Vinholt PJ; Alnor A; Nybo M; Hvas AM
Platelets; 2016 Sep; 27(6):547-54. PubMed ID: 27025360
[TBL] [Abstract][Full Text] [Related]
34. New thoughts on the correct dosing of prophylactic platelet transfusions to prevent bleeding.
Slichter SJ
Curr Opin Hematol; 2011 Nov; 18(6):427-35. PubMed ID: 21946073
[TBL] [Abstract][Full Text] [Related]
35. Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients.
Slichter SJ
J Clin Apher; 2006 Apr; 21(1):78-84. PubMed ID: 16619231
[TBL] [Abstract][Full Text] [Related]
36. Different Platelet Count Thresholds to Guide Use of Prophylactic Platelet Transfusions for Patients With Hematological Disorders After Myelosuppressive Chemotherapy or Stem Cell Transplantation.
Estcourt LJ; Stanworth SJ; Murphy MF
JAMA Oncol; 2016 Aug; 2(8):1091-2. PubMed ID: 27415031
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of prophylactic transfusions using single donor apheresis platelets versus pooled platelet concentrates in AML/MDS patients receiving allogeneic hematopoietic stem cell transplantation.
Gurkan E; Patah PA; Saliba RM; Ramos CA; Anderson BS; Champlin R; de Lima M; Lichtiger B
Bone Marrow Transplant; 2007 Sep; 40(5):461-4. PubMed ID: 17589530
[TBL] [Abstract][Full Text] [Related]
38. Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies.
Antun AG; Gleason S; Arellano M; Langston AA; McLemore ML; Gaddh M; el Rassi F; Bernal-Mizrachi L; Galipeau J; Heffner LT; Winton EF; Khoury HJ
Cancer; 2013 Nov; 119(21):3784-7. PubMed ID: 23921838
[TBL] [Abstract][Full Text] [Related]
39. Do all patients with hematologic malignancies and severe thrombocytopenia need prophylactic platelet transfusions? Background, rationale, and design of a clinical trial (trial of platelet prophylaxis) to assess the effectiveness of prophylactic platelet transfusions.
Stanworth SJ; Dyer C; Choo L; Bakrania L; Copplestone A; Llewelyn C; Norfolk D; Powter G; Littlewood T; Wood EM; Murphy MF;
Transfus Med Rev; 2010 Jul; 24(3):163-71. PubMed ID: 20656185
[TBL] [Abstract][Full Text] [Related]
40. Randomized Trial of Platelet-Transfusion Thresholds in Neonates.
Curley A; Stanworth SJ; Willoughby K; Fustolo-Gunnink SF; Venkatesh V; Hudson C; Deary A; Hodge R; Hopkins V; Lopez Santamaria B; Mora A; Llewelyn C; D'Amore A; Khan R; Onland W; Lopriore E; Fijnvandraat K; New H; Clarke P; Watts T;
N Engl J Med; 2019 Jan; 380(3):242-251. PubMed ID: 30387697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
